Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move (NYSE: $ACB) (TSX: $ACB.TO) (CSE: $DIXI_U.C) (OTCQX: $DXBRF) (TSXV: $META.V) (CSE: $HITI.C) (TSXV: $PCLO.V)
Delta, Kelowna, BC –July 25, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/07251ACB-DIXI-DXBRF-META-HITI-PLCO.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), and the UFC announced the launch of a joint clinical research program that will produce multiple studies under the terms of their recently announced partnership.
The research will examine the use of hemp-derived CBD as an effective treatment for pain, inflammation, wound-healing, and recovery on MMA athletes.
The ground-breaking research partnership is aimed at understanding key health and recovery needs of elite athletes in such a highly physical and competitive sport as mixed martial arts. Research data will then be used to drive the development of science-backed, hemp-derived CBD topicals that will be safe and reliable. These new products will help combat the rapidly growing market of untested CBD treatments currently being used by high-performance and non-professional athletes.
Once research is complete, any resulting product will come to life in the U.S. under the new high-performance sports brand ROAR Sports, a portfolio of high-quality, hemp-derived CBD topical treatments scientifically formulated with elite athletes in mind. Through analysis of athlete needs and scientific data, ROAR Sports will challenge the status quo, seek to alleviate the stresses of competition, and earn designation as the "Official CBD product of UFC."
The multi-phase clinical study at the UFC Performance Institute® in Las Vegas will be led by Dr. Jason Dyck, Chair of Aurora's Global Scientific Oversight Committee; Dr. Kelly Narine, Aurora's Vice President Global Research and Medical Affairs; and the team of sports performance experts at the UFC Performance Institute, led by Dr. Duncan French, UFC Vice President of Performance. Using active UFC athletes on a strictly voluntary basis, the study will help establish peer-reviewed, publishable research in this area. Products will be developed in full compliance with U.S. federal law and with UFC's anti-doping program, which adheres to WADA and USADA regulations.
"Our partnership with UFC is about committing to the science that will educate and advocate," said Aurora CEO Terry Booth. "We are going to work together to change the way people think, to change the industry, and to launch the first hemp-derived CBD products that are backed by scientific research. The brand-building and product development are all part of our move into the U.S., and in collaboration with UFC, and we intend to play a major role in that market."
"We know anecdotally that professional athletes across sports disciplines are turning to hemp-derived CBD treatments to assist with physical recovery, with varying degrees of success," added Jason Dyck, Chair of Aurora's Global Scientific Oversight Committee. "The work we do in partnership with UFC will create an evidence-based, science-backed pipeline of consistent, and 'clean' hemp-derived CBD topicals that the high-performance athletes of UFC can rely on to treat the pain, inflammation, injury and other conditions associated with competing at such a high level."
Dixie Brands Inc. (CSE: DIXI.U) (OTCQX: DXBRF) today announced a breakthrough in THC water solubility via a proprietary emulsification technique and ingredient management process offering marked improvements in uptake in cannabis-infused liquids.
Dixie Brands will showcase the proprietary process via the launch of a new product line of flavored and unflavored drink additives called FUSE in the fourth quarter of this year. In addition, Dixie will implement the new process across its existing line of award-winning beverages and tinctures as part of its never-ending drive to deliver the best possible consumption experience to consumers, a heritage going back nearly 10 years since the launch of the original Dixie Elixir.
"Dixie was among the first to market with a cannabis-infused beverage nearly a decade ago, and we have remained at the forefront of research and development ever since," said Chuck Smith, CEO of Dixie Brands. "That focus on innovation has enabled us to expand into 15 product categories, and like any other successful CPG company, we are always striving to improve our product offerings. A faster-acting formula is the next step in our ongoing quest to better serve our patients and consumers."
Cannabis-infused beverages offer a bridge for "canna-curious" consumers seeking an alternative to alcohol. The millennial demographic has been driving a growth trend in the category. By improving uptake times and introducing FUSE drink additives that can enhance non-alcoholic beverages, Dixie expects to increase the appeal of its products to these consumers and expand its addressable market.
National Access Cannabis Corp. (TSXV: META), today announced it has received two additional licences from the Alberta Gaming, Liquor and Cannabis Commission to open cannabis retail stores in Alberta. The retail stores will be located in Leduc and Calgary.
"With seven new licences granted in Alberta since the lifting of the moratorium by the AGLC on May 30th, we continue to expand our private cannabis retailing footprint in Alberta," said Mark Goliger, CEO of NAC. "Today we have the largest footprint of retail cannabis stores in Canada1, and we expect to maintain this position by continuing to pursue expansion opportunities, particularly in British Columbia and Ontario."
NAC is the national leader in retail cannabis1. Currently operating in three provinces, NAC has applied for licences in British Columbia and plans to make applications for licences in Ontario. NAC's experienced team of retail industry professionals is focused on achieving its business plan of having 40 operating stores by the end of calendar 2019, and 110 operating stores by the end of calendar 2020.
High Tide Inc. (CSE:HITI) (OTCQB:HITIF) today announced that the Canna Cabana retail stores located in the city of Beaumont, a franchised store located in Calgary and in Lacombe all received their first deliveries of cannabis products from Alberta Gaming, Liquor and Cannabis ("AGLC") and have begun selling recreational cannabis for adult use. The New Alberta Stores bring the total number of Canna Cabana retail locations currently selling recreational cannabis to a total of 14 branded locations across Canada.
High Tide expects its next 7 Canna Cabana locations and the first KushBar location to be licensed as retail cannabis stores by the end of August, which will bring its total number to 22 locations across Canada, barring any changes to the current rate of licensing by AGLC.
"Bringing the Canna Cabana experience to the community of Kensington in Calgary and the cities of Beaumont and Lacombe not only supports the expansion of High Tide's retail segment but it also boosts the wholesale segment as these locations feature our wide range of proprietary smoking accessories," said Raj Grover, President and Chief Executive Officer of High Tide. "Out staff is excited to sell recreational cannabis products at the New Alberta Stores and we look forward to continuing the rapid rate of growth that has taken Canna Cabana from 4 to 10 Alberta locations within a month," added Mr. Grover.
The remaining Canna Cabana and KushBar locations needed to achieve the AGLC's maximum of 15% market share are currently under various stages of development and construction. Outside of Alberta, High Tide currently has a Canna Cabana retail cannabis store in Swift Current, Saskatchewan, along with 3 branded locations in Hamilton, Sudbury and Toronto, Ontario. High Tide is also progressing toward closing the previously announced acquisition of a second location in Saskatchewan, establishing a retail cannabis presence in Manitoba and opening the maximum number of 8 locations in British Columbia.
PharmaCielo Ltd. (TSXV:PCLO) (OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announced today that it has completed the necessary permitting process required to enable Colombia's first commercial export and sale of non-psychoactive (CBD) isolate.
The extensive process fulfils the extensive and final regulatory obligations required, including individual approvals by the Colombian Ministries of Health and Justice, in order to commence product exportation. With this prerequisite accomplished, the Company will begin the process of confirming a series of international business relationships and configuring inaugural commercial shipments of high-grade medicinal CBD isolate, with a purity certificate of analysis (COA) of 99+% and meeting all other strict quality control standard requirements established by the Colombian government.
"Enabling product delivery to customers is one of the most exciting and memorable moments for any company, and we are thrilled about this accomplishment," said David Attard, CEO of PharmaCielo Ltd. "This specific point in time not only distills the vision, hard work, dedication and commitment of our team, but also signifies the transition of PharmaCielo from a founding stage into a mature company with the infrastructure of production, distribution and sales operations that can deliver high-quality products to its clients."
PharmaCielo is currently in advanced discussion with previously identified potential customers in multiple global markets, as part of which the export permitting process is a necessity, including logistical relations with its joint venture partners in Italy and Mexico. Upon closure of the acquisition of Creso Pharma Ltd., expected later in the year, the number of potential international markets for PharmaCielo products export will significantly increase.
"We have already begun scaling up our Colombian operations and we are ready to deliver and prepared to support the expected growth in demand for our cannabinoid extracts, having achieved the Colombian industry's first go-ahead to start exporting," said Andres Botero, Chief Operations Officer with PharmaCielo Colombia Holdings S.A.S.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment